MiR-592 represses FOXO3 expression and promotes the proliferation of prostate cancer cells

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 15246-15253

  Lv, Zhonghua ^a   Rao, Pinlang ^b   Li, Wenlin ^c  

^a Shandong Jining First People s Hospital   (China)

^b The Second Hospital of Jiangxi Province Nanchang City   (China)

^c Rizhao Traditional Chinese Medicine Hospital of Shandong Traditional Chinese Medicine University   (China)

Author keywords

Cell proliferation; FOXO3; miR 592; Prostate cancer

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 592; NUCLEIC ACID SYNTHESIS INHIBITOR; PROTEIN P21; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MTT ASSAY; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84946558037     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64: 252-271.
3. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
4. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
5. Sun K and Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet 2013; 14: 535-548.
6. Cao L, Xie B, Yang X, Liang H, Jiang X, Zhang D, Xue P, Chen D and Shao Z. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. PLoS One 2015; 10: e0133074.
7. Yang F, Wang W, Zhou C, Xi W, Yuan L, Chen X, Li Y, Yang A, Zhang J and Wang T. MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumour Biol 2015; 36: 3763-3773.
8. Deng L and Liu H. MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6. Int J Clin Exp Med 2015; 8: 1862-1870.
9. Kong XJ, Duan LJ, Qian XQ, Xu D, Liu HL, Zhu YJ and Qi J. Tumor-suppressive microRNA-497 targets IKKbeta to regulate NF-kappaB signaling pathway in human prostate cancer cells. Am J Cancer Res 2015; 5: 1795-1804.
10. Wang LQ, Zhang Y, Yan H, Liu KJ and Zhang S. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Biochem Biophys Res Commun 2015; 459: 515-520.
11. Lan G, Yang L, Xie X, Peng L and Wang Y. MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer. Arch Med Sci 2015; 11: 561-569.
12. Fang Y, Zhu X, Wang J, Li N, Li D, Sakib N, Sha Z and Song W. MiR-744 functions as a protooncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5. Oncotarget 2015; 6: 13164-13175.
13. Nho RS, Im J, Ho YY and Hergert P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am J Physiol Lung Cell Mol Physiol 2014; 307: L632-642.
14. Wang D, Zhang H, Li M, Frid MG, Flockton AR, McKeon BA, Yeager ME, Fini MA, Morrell NW, Pullamsetti SS, Velegala S, Seeger W, McKinsey TA, Sucharov CC and Stenmark KR. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 2014; 114: 67-78.
15. Liang WL, Cao J, Xu B, Yang P, Shen F, Sun Z, Li WL, Wang Q and Liu F. miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells. Biomed Pharmacother 2015; 72: 119-124.
16. Jiang C, Chen X, Alattar M, Wei J and Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015; 22: 291-301.
17. Chen S, Chen X, Xiu YL, Sun KX and Zhao Y. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. Cancer Lett 2015; 362: 122-130.
18. He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z and Duan C. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol Cancer 2015; 14: 73.
19. Smith AR, Marquez RT, Tsao WC, Pathak S, Roy A, Ping J, Wilkerson B, Lan L, Meng W, Neufeld KL, Sun XF and Xu L. Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression. Oncotarget 2015; 6: 12558-12573.
20. Shen F, Cai WS, Feng Z, Li JL, Chen JW, Cao J and Xu B. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression. Tumour Biol 2015; 36: 1913-1921.
21. Hui Z, Yiling C, Wenting Y, XuQun H, ChuanYi Z and Hui L. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERalphapositive breast cancer. FEBS Lett 2015; 589: 812-821.
22. Liu Z, Wu R, Li G, Sun P, Xu Q and Liu Z. MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression. Int J Clin Exp Med 2015; 8: 3490-3497.
23. Liu M, Zhi Q, Wang W, Zhang Q, Fang T and Ma Q. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Biomed Pharmacother 2015; 69: 214-220.
24. Zhao X, Liu Y, Du L, He L, Ni B, Hu J, Zhu D and Chen Q. Threonine 32 (Thr32) of FoxO3 is critical for TGF-beta-induced apoptosis via Bim in hepatocarcinoma cells. Protein Cell 2015; 6: 127-138.
25. Li J, Li P, Chen T, Gao G, Chen X, Du Y, Zhang R, Yang R, Zhao W, Dun S, Gao F and Zhang G. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumour Biol 2015; 36: 685-692.